Theravance Biopharma (TBPH) Interest Coverage Ratio (2016 - 2025)
Theravance Biopharma (TBPH) has disclosed Interest Coverage Ratio for 10 consecutive years, with 11.26 as the latest value for Q3 2025.
- On a quarterly basis, Interest Coverage Ratio changed N/A to 11.26 in Q3 2025 year-over-year; TTM through Sep 2025 was 13.01, a 47.35% increase, with the full-year FY2024 number at 3.61, up 81.9% from a year prior.
- Interest Coverage Ratio was 11.26 for Q3 2025 at Theravance Biopharma, down from 4.11 in the prior quarter.
- In the past five years, Interest Coverage Ratio ranged from a high of 2.26 in Q2 2022 to a low of 45.29 in Q1 2023.
- A 5-year average of 16.64 and a median of 14.38 in 2023 define the central range for Interest Coverage Ratio.
- Peak YoY movement for Interest Coverage Ratio: tumbled 279.16% in 2021, then soared 83.15% in 2025.
- Theravance Biopharma's Interest Coverage Ratio stood at 25.1 in 2021, then fell by 26.27% to 31.69 in 2022, then soared by 54.62% to 14.38 in 2023, then increased by 0.53% to 14.31 in 2024, then increased by 21.28% to 11.26 in 2025.
- Per Business Quant, the three most recent readings for TBPH's Interest Coverage Ratio are 11.26 (Q3 2025), 4.11 (Q2 2025), and 22.45 (Q1 2025).